Johnson & Johnson (J&J) has proposed a $5.5 billion settlement to resolve tens of thousands of U.S. lawsuits alleging that its talc-based baby powder and related products cause ovarian cancer. The settlement, which covers approximately 76,000 cases, aims to finalize a long-standing legal dispute that has impacted the company for years. J&J denies the allegations, stating that its products are safe and do not contain asbestos. The company plans to offer up to $3 billion in payments starting next year, with no additional payments required before 2028. Legal representatives must approve the settlement for it to become final. J&J has previously stopped selling talc-based baby powder globally and shifted to cornstarch-based alternatives. Courts have raised questions about whether plaintiffs can prove a direct causal link between talc and ovarian cancer.
Bias read (Center): The article presents a balanced account of the legal dispute, quoting both J&J's denial of wrongdoing and the plaintiffs' claims. It reports on the company's stance, the legal process, and scientific arguments without overtly favoring either side. The framing remains neutral, focusing on factual and




